Drugs Approved Faster in US, Cost More


According to a study by the Tufts Center for the Study of Drug Development, more cancer drugs were approved in the US than in the EU during the 2010-2011 time period. However, these drugs cost more in the US; cost is not as closely tied to reimbursement in the US as it is in Europe.

Read an article about the report here